Oculis' Series B Round

Oculis raised a round of funding on January 04, 2018.

Oculis is a clinical stage biotechnology company focused on the development of novel and transformative topical treatments (eye drops) for ophthalmic diseases for both back and front of the eye.…

Articles about Oculis' Series B Round: